Form S-3 Tonix Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500, Nasdaq advance as soft inflation tempers Fed rate-hike bets
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Tonix Pharma (TNXP) Files $500M Mixed Shelf
June 12, 2025 6:04 AM EDTTonix Pharma (NASDAQ: TNXP) has filed $500,000,000 mixed shelf of:
Common Stock
Preferred Stock
Warrants
Debt Securities
Subscription Rights
Units
... More